Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$462M |
| 2 |
NVIDIA
NVDA
|
+$385M |
| 3 |
Meta Platforms (Facebook)
META
|
+$311M |
| 4 |
Apple
AAPL
|
+$301M |
| 5 |
EXE
Expand Energy Corp
EXE
|
+$294M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SWN
Southwestern Energy Company
SWN
|
+$381M |
| 2 |
ExxonMobil
XOM
|
+$352M |
| 3 |
MRO
Marathon Oil Corporation
MRO
|
+$223M |
| 4 |
VSTO
Vista Outdoor Inc.
VSTO
|
+$136M |
| 5 |
SoFi Technologies
SOFI
|
+$135M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.43% |
| 2 | Financials | 18.32% |
| 3 | Industrials | 12.45% |
| 4 | Consumer Discretionary | 10.88% |
| 5 | Healthcare | 9.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2226
Lucid Motors
LCID
$1.79B
| $12.2M | ﹤0.01% |
403,493
+20,822
| +5% | +$542K |
|
|
ONIT
2227
Onity Group
ONIT
$287M
| $12.2M | ﹤0.01% |
396,558
+19,960
| +5% | +$618K |
|
|
GATO
2228
DELISTED
Gatos Silver, Inc.
GATO
| $12.1M | ﹤0.01% |
868,777
-179,549
| -17% | -$2.92M |
|
2229
Arcturus Therapeutics
ARCT
$478M
| $12M | ﹤0.01% |
707,404
-85,196
| -11% | -$1.6M |
|
2230
West Fraser Timber
WFG
$5.71B
| $12M | ﹤0.01% |
138,435
+14,189
| +11% | +$1.33M |
|
2231
New Fortress Energy
NFE
$70.2M
| $12M | ﹤0.01% |
15,848
-6,493
| -29% | -$3.36M |
|
2232
Prothena Corp
PRTA
$423M
| $12M | ﹤0.01% |
864,833
+10,783
| +1% | +$170K |
|
|
TRUE
2233
DELISTED
TrueCar
TRUE
| $12M | ﹤0.01% |
3,207,313
-38,433
| -1% | -$151K |
|
2234
Anterix
ATEX
$1.51B
| $11.9M | ﹤0.01% |
389,593
-12,497
| -3% | -$415K |
|
2235
York Water
YORW
$535M
| $11.9M | ﹤0.01% |
364,566
-8,757
| -2% | -$312K |
|
2236
Vanda Pharmaceuticals
VNDA
$303M
| $11.9M | ﹤0.01% |
2,488,519
+227,428
| +10% | +$1.09M |
|
2237
Hooker Furnishings Corp
HOFT
$139M
| $11.9M | ﹤0.01% |
850,670
+447
| +0.1% | +$7.52K |
|
2238
Cytek Biosciences
CTKB
$643M
| $11.9M | ﹤0.01% |
1,830,432
+262,607
| +17% | +$1.56M |
|
2239
Peoples Financial Services
PFIS
$710M
| $11.9M | ﹤0.01% |
232,031
+9,889
| +4% | +$503K |
|
2240
Bridgewater Bancshares
BWB
$583M
| $11.9M | ﹤0.01% |
877,833
+40,683
| +5% | +$598K |
|
2241
LG Display
LPL
$3.01B
| $11.8M | ﹤0.01% |
3,847,872
-9,196
| -0.2% | -$32.4K |
|
2242
nLIGHT
LASR
$2.27B
| $11.8M | ﹤0.01% |
1,126,972
-36,422
| -3% | -$405K |
|
2243
Civeo
CVEO
$349M
| $11.8M | ﹤0.01% |
517,457
+35,648
| +7% | +$893K |
|
|
DAWN
2244
DELISTED
Day One Biopharmaceuticals
DAWN
| $11.7M | ﹤0.01% |
927,017
+90,822
| +11% | +$1.26M |
|
2245
Future Fuel
FF
$237M
| $11.7M | ﹤0.01% |
2,218,292
+169,438
| +8% | +$945K |
|
|
CTLP
2246
DELISTED
Cantaloupe
CTLP
| $11.7M | ﹤0.01% |
1,231,728
+68,546
| +6% | +$624K |
|
2247
Embecta
EMBC
$288M
| $11.7M | ﹤0.01% |
566,993
+73,165
| +15% | +$1.2M |
|
2248
Simulations Plus
SLP
$373M
| $11.7M | ﹤0.01% |
419,241
+24,266
| +6% | +$739K |
|
2249
TETRA Technologies
TTI
$931M
| $11.7M | ﹤0.01% |
3,259,133
+239,052
| +8% | +$849K |
|
2250
Recursion Pharmaceuticals
RXRX
$1.81B
| $11.5M | ﹤0.01% |
1,708,040
-9,739
| -0.6% | -$65.5K |
|
Similar funds
Dimensional Fund Advisors's Q4 2024 Portfolio in Review
As of Q4 2024, Dimensional Fund Advisors held 3,410 positions worth $416B, up 0.99% from $412B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Trading was light in Q4 2024: portfolio turnover was 3.9%. Dimensional Fund Advisors opened 61 new positions and exited 71, leaving the 3,410-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Industrials.
- Dimensional Fund Advisors's largest Q4 2024 buy was Everus Construction Group: 1,833,827 shares worth $121M.
- Dimensional Fund Advisors added most to Merck in Q4 2024, an estimated $462M increase.
- Dimensional Fund Advisors's biggest Q4 2024 reduction was ExxonMobil, cutting an estimated $352M.
- Dimensional Fund Advisors fully exited Southwestern Energy Company in Q4 2024, selling an estimated $381M.
- Dimensional Fund Advisors's ten largest holdings make up 16% of its $416B portfolio in Q4 2024.
- Dimensional Fund Advisors opened 61 new positions and closed 71 in Q4 2024.
- Dimensional Fund Advisors's portfolio value rose 0.99% quarter-over-quarter to $416B.
Based on Dimensional Fund Advisors's 13F filing for Q4 2024, filed 13 Feb 2025.